SN
Shuja Noorani
About Shuja Noorani
Data last updated:
Shuja Noorani is a Director at Catlin Pharmaceuticals Private Limited (since 2025). The company operates in Pharma. Catlin Pharmaceuticals Private Limited reported revenue of ₹1.01 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Catlin Pharmaceuticals Private Limited U24290MH2022PTC389693 | Director | 21 Aug 2025 | 2022 | ₹1.01 Cr (FY 2024) | Active |
Board colleagues of Shuja Noorani
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kul Bhushan Wanchoo | 09722740 | Catlin Pharmaceuticals Private Limited | Director |
| Kunal Khanna | 08878875 | Catlin Pharmaceuticals Private Limited | Director |
| Manik Kak | 09758738 | Catlin Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shuja Noorani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shuja Noorani
Shuja Noorani currently holds 1 directorship: Catlin Pharmaceuticals Private Limited (Director, since 21 Aug 2025, revenue ₹1.01 Cr (FY 2024)).
Shuja Noorani was first appointed on 21 Aug 2025 as Director at Catlin Pharmaceuticals Private Limited.
The current boards of Shuja Noorani's companies include Kul Bhushan Wanchoo (Catlin Pharmaceuticals Private Limited), Kunal Khanna (Catlin Pharmaceuticals Private Limited), Manik Kak (Catlin Pharmaceuticals Private Limited).